University of Patras
Δια-ιστικά πρότυπα έκφρασης βιοδεικτών-κλειδί του μεταβολισμού σε ασθενείς με κλινικά σοβαρή παχυσαρκία: επίπτωση στην επαγόμενη από την παχυσαρκία νόσο
Abstract
dc:descriptionBackground: Obesity is a global epidemic which is associated with several cardiometabolic comorbidities and is characterized by chronic, low grade systemic inflammation. Numerous biomarkers have been implicated in the pathophysiology of the disease, including transcription factors and coregulators. Obesity is characterized by a chronic, low grade, systemic inflammation and there is evidence that nonalcoholic fatty liver disease (NAFLD) and insulin resistance are strongly related to the underlying inflammatory process. For example, Steroid Receptor Coactivator (SRC)-family are prime regulators of metabolic pathways in different tissues and disturbance of their expression corresponds to various physiological abnormalities and metabolic disorders. Although adipose tissue has been the target of interest among researchers for the last two decades, little is known about the precise mechanics in human metabolism and obesity. For example, it was recently found that skeletal muscle, not only plays a pivotal role in glucose homeostasis, but also represents an active metabolic organ whose activities need to be determined. Molecules studied included: PGC1α, which is already known as a significant regulator of mitochondrial biogenesis, oxidative phosphorylation and fatty acid metabolism. Many of those mediators are either targets or activators of nuclear factor-κappa B (NFκB), which is a key transcription factor and plays a pivotal role in the homeostasis and the regulation of inflammatory signaling pathways in the liver.Aim: The purpose of the present study was to determine the relationship between patients with morbid obesity, their underlying non-alcoholic fatty liver disease, diabetes, as well as to explore any potential associations with clinicopathological parameters. Our study focuses on the role of PPARγ, NFκΒ, PGC1a in human metabolism, based on their expression, evaluated by immunohistochemistry, in five different tissue samples, collected from 50 morbidly obese patients before undertaking planned bariatric surgery.Methods: The study population consists of 50 morbidly obese patients undergoing planned bariatric surgery, during which biopsies were taken from visceral adipose tissue (VAT), subcutaneous adipose tissue (SAT), skeletal muscle (SM), extramyocellular adipose tissue (EMAT) and liver. The presence of macrophages and lymphocytes was evaluated, by assessing the expression of CD68 and CD3 biomarkers by immunohistochemistry in the collected tissues. Potential correlations with clinicopathological parameters and with the development of diabetes and non-alcoholic fatty liver disease (NAFLD) were also explored. We further, evaluated the differential protein expression of NFκB and PGC1a (peroxisome proliferator-activated receptor gamma coactivator 1-alpha) by immunohistochemistry. The current study was designed to determine any correlations between the inflammatory mediators PPARγ, NFκB with the coregulator PGC1a, which have already established their vital role in obesity-induced metabolic diseases.Results: Our findings suggest a complex inter- and intra-tissue co-expression network that links obesity-induced inflammation in adipose depots and skeletal muscle with non-alcoholic fatty liver disease. Novel finding is the intricate cross-talk between skeletal muscle (SM) and its extramyocellular adipose tissue (EMAT) with the liver and the causal relationship between SM and EMAT inflammation and progression to liver fibrosis. Our findings have highlighted complex inter-tissue PGC1α expression patterns. Moreover, we found significant negative correlations between PGC1a expression in VAT with CD68 expression in skeletal muscle and EMAT, suggesting a protective role of PGC1a against obesity-induced inflammation. Finally, we have enough evidence to assume a beneficial role of PGC1a against obesity-induced disease, such as type II diabetes (T2DM) and non-alcoholic fatty liver disease (NAFLD). We demonstrated an extensive intra- and intertissue co-expression network, which confirms the tissue-specific and integral role of each one of the investigated proteins in human metabolism. Moreover, a beneficial role of ERβ against NAFLD is implicated, whereas the distinct roles of TIF2 still remain an enigma.We demonstrated an extensive intra- and intertissue co-expression network, which confirms the tissue-specific and integral role of each one of the investigated proteins in human metabolism. We found that NFκB is the key biomarker in a complicated intra- and intertissue coexpression network, that interconnects metabolic and immune signaling pathways. We also demonstrated its role in lipid metabolism and possibly in the development of skeletal muscle insulin resistance and non alcoholic steatohepatitis (NASH). Moreover, we revealed a complex and extensive multi-tissue network between the three main investigated proteins and the inflammatory biomarkers, suggesting their participation in the obesity-induced inflammatory cascade. Conclusions: Although the mechanisms of obesity-induced inflammation and its association with NAFLD and liver fibrosis are incompletely understood, our findings indicate an extensive and complex tissue network that needs to be further investigated. We believe that our study will contribute to the understanding of the common underlying mechanisms among the interlinked pathologies in order to identify potential therapeutic and prognostic targets. We believe that our study will give more insight into the role of PGC1a in the underlying mechanisms of obesity and its comorbidities and we hope that it could represent a potential preventive and therapeutic target against obesity-induced disease, probably through enhancing mitochondrial biogenesis and metabolism. We hope that our findings will shed light on the complex underlying mechanisms and that the investigated biomarkers could represent future targets for the prevention and therapy of obesity and its comorbidities. Our findings suggest that NFκB may be the critical link between immune and metabolic pathways and could represent a future preventive and therapeutic target against obesity-induced metabolic diseases. We hope that our study will contribute to the better understanding of the complex intertissue connections that are disrupted in obesity and its associated comorbidities. Steroid receptor coactivators have emerged as an important new class of functional proteins that participate along with many transcription factors and inflammatory biomarkers, in regulating gene expression in response to a wide variety of environmental triggers. We hope that our study will contribute to the better understanding of the complex multi-tissue connections that are disrupted in obesity and can therefore lead in numerous cardiometabolic diseases.
Degree
thesis:*- Grantor dc:publisher
- University of Patras
- Year dc:date
- 2019
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Balampanis, Konstantinos
- Μπαλαμπάνης, Κωνσταντίνος
Subjects
dc:subject × 19Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/45815